{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:20:19Z","timestamp":1792686019784,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.anai.2018.07.036","type":"journal-article","created":{"date-parts":[[2018,8,4]],"date-time":"2018-08-04T13:55:14Z","timestamp":1533390914000},"page":"613-618","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["IgE deficiency and prior diagnosis of malignancy"],"prefix":"10.1016","volume":"121","author":[{"given":"Denisa","family":"Ferastraoaru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Rosenstreich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anai.2018.07.036_bib0001","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.jaci.2016.04.009","article-title":"Fifty years later: emerging functions of IgE antibodies in host defense, immune regulation, and allergic diseases","volume":"137","author":"Oettgen","year":"2016","journal-title":"J Allergy Clin Immunol."},{"key":"10.1016\/j.anai.2018.07.036_bib0002","first-page":"161","article-title":"Cancer incidence in 13811 patients skin tested for allergy","volume":"15","author":"Eriksson","year":"2005","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.anai.2018.07.036_bib0003","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1093\/annonc\/mdv231","article-title":"IgE and risk of cancer in 37 747 individuals from the general population","volume":"26","author":"Helby","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.anai.2018.07.036_bib0004","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1398-9995.2005.00808.x","article-title":"Allergy and cancer","volume":"60","author":"Lindel\u00f6f","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2018.07.036_bib0005","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1016\/j.ejca.2006.04.021","article-title":"Autoimmune diseases, asthma and risk of haematological malignancies: a nationwide case-control study in Sweden","volume":"42","author":"Soderberg","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.anai.2018.07.036_bib0006","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2249.2008.03726.x","article-title":"Immunoglobulin E antibodies from pancreatic cancer patients mediate antibody-dependent cell-mediated cytotoxicity against pancreatic cancer cells","volume":"153","author":"Fu","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.anai.2018.07.036_bib0007","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/eji.200323185","article-title":"Activity of human monocytes in IgE antibody-dependent surveillance and killing of ovarian tumor cells","volume":"33","author":"Karagiannis","year":"2003","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.anai.2018.07.036_bib0008","first-page":"5715","article-title":"Immunoglobulin E induces colon cancer cell apoptosis via enhancing cyp27b1 expression","volume":"8","author":"Ye","year":"2016","journal-title":"Am J Trans Res"},{"key":"10.1016\/j.anai.2018.07.036_bib0009","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000236714","article-title":"Distribution of immunoglobulins in squamous cell carcinoma of the head and neck","volume":"104","author":"Neuchrist","year":"1994","journal-title":"Intl Arch Allergy Immunol"},{"key":"10.1016\/j.anai.2018.07.036_bib0010","first-page":"109","article-title":"IgE immunotherapy against cancer","volume":"388","author":"Leoh","year":"2015","journal-title":"Curr Topics Microbiol Immunol"},{"key":"10.1016\/j.anai.2018.07.036_bib0011","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/1471-2407-13-195","article-title":"A novel IgE antibody targeting the prostate-specific antigen as a potential prostate cancer therapy","volume":"13","author":"Daniels-Wells","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.anai.2018.07.036_bib0012","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00262-008-0607-1","article-title":"Characterisation of an engineered trastuzumab IgE antibody and effector cell mechanisms targeting HER2\/neu-positive tumour cells","volume":"58","author":"Karagiannis","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.anai.2018.07.036_bib0013","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF01741326","article-title":"Growth inhibition of murine mammary carcinoma by monoclonal IgE antibodies specific for the mammary tumor virus","volume":"34","author":"Nagy","year":"1991","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.anai.2018.07.036_bib0014","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4049\/jimmunol.1101842","article-title":"An antitumor cellular vaccine based on a mini-membrane IgE","volume":"188","author":"Nigro","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.anai.2018.07.036_bib0015","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1093\/carcin\/bgu188","article-title":"Prediagnostic immunoglobulin E levels and risk of chronic lymphocytic leukemia, other lymphomas and multiple myeloma-results of the European Prospective Investigation into Cancer and Nutrition","volume":"35","author":"Nieters","year":"2014","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.anai.2018.07.036_bib0016","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.anai.2017.07.006","article-title":"Increased malignancy incidence in IgE deficient patients not due to concomitant common variable immunodeficiency","volume":"119","author":"Ferastraoaru","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2018.07.036_bib0017","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.2500\/aap.2014.35.3734","article-title":"Selective IgE deficiency, immune dysregulation, and autoimmunity","volume":"35","author":"Magen","year":"2014","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.anai.2018.07.036_bib0018","series-title":"National Health and Nutrition Examination Survey Data","year":"2016"},{"key":"10.1016\/j.anai.2018.07.036_bib0019","series-title":"United States Cancer Statistics: 1999-2014 Incidence and Mortality Web-based Report","year":"2017"},{"key":"10.1016\/j.anai.2018.07.036_bib0020","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/cea.12178","article-title":"Epidemiological associations of allergy, IgE and cancer","volume":"43","author":"Joseph","year":"2013","journal-title":"Clin Exp Allergy."},{"key":"10.1016\/j.anai.2018.07.036_bib0021","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/294213","article-title":"Inverse association between prediagnostic IgE levels and the risk of brain tumors: a systematic review and meta-analysis","volume":"2015","author":"Ma","year":"2015","journal-title":"Biomed Res Int"},{"issue":"10","key":"10.1016\/j.anai.2018.07.036_bib0022","first-page":"1657","article-title":"Immunoglobulin E and cancer: a meta-analysis and a large Swedish cohort study","volume":"21","author":"Van Hemelrijck","year":"2010","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.anai.2018.07.036_bib0023","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1158\/1055-9965.EPI-07-0176","article-title":"Immunoglobulin E levels and risk of lymphoma in a case-control study in Spain","volume":"16","author":"Ellison-Loschmann","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.anai.2018.07.036_bib0024","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/jnci\/djk019","article-title":"Atopy and risk of non-Hodgkin lymphoma","volume":"99","author":"Melbye","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.anai.2018.07.036_bib0025","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s12016-016-8559-2","article-title":"Atopy and specific cancer sites: a review of epidemiological studies","volume":"51","author":"Cui","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.anai.2018.07.036_bib0026","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00277-017-3175-7","article-title":"Delayed recovery of serum immunoglobulin G is a poor prognostic marker in patients with follicular lymphoma treated with rituximab maintenance","volume":"97","author":"Kusano","year":"2018","journal-title":"Ann Hematol"},{"key":"10.1016\/j.anai.2018.07.036_bib0027","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.clml.2012.11.011","article-title":"Incidence of hypogammaglobulinemia in patients receiving rituximab and the use of intravenous immunoglobulin for recurrent infections","volume":"13","author":"Casulo","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.anai.2018.07.036_bib0028","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/j.1398-9995.2008.01768.x","article-title":"AllergoOncology: the role of IgE-mediated allergy in cancer","volume":"63","author":"Jensen-Jarolim","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2018.07.036_bib0029","doi-asserted-by":"crossref","first-page":"740","DOI":"10.6061\/clinics\/2014(11)06","article-title":"Total IgE plasma levels vary according to gender and age in Brazilian patients with allergic rhinitis","volume":"69","author":"Paula Couto","year":"2014","journal-title":"Clinics (Sao Paulo"},{"key":"10.1016\/j.anai.2018.07.036_bib0030","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1365-2222.1994.tb00950.x","article-title":"Total and specific serum IgE levels in adults: relationship to sex, age and environmental factors","volume":"24","author":"Omenaas","year":"1994","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.anai.2018.07.036_bib0031","first-page":"57","article-title":"Role of Gender and serum immunoglobulin E (IGE) levels on severity of migraine","volume":"8","author":"Rosario","year":"2014","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.anai.2018.07.036_bib0032","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0091-6749(80)90026-3","article-title":"Age-related serum immunoglobulin E levels in healthy subjects and in patients with allergic disease","volume":"66","author":"Wittig","year":"1980","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2018.07.036_bib0033","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cyto.2015.05.026","article-title":"Targeting of IL-4 and IL-13 receptors for cancer therapy","volume":"75","author":"Suzuki","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.anai.2018.07.036_bib0034","doi-asserted-by":"crossref","first-page":"28743","DOI":"10.1074\/jbc.M113.499053","article-title":"Interleukin-4 induces senescence in human renal carcinoma cell lines through STAT6 and p38 MAPK","volume":"288","author":"Kim","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.anai.2018.07.036_bib0035","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1158\/1535-7163.MCT-17-0339","article-title":"IL4 Receptor-targeted proapoptotic peptide blocks tumor growth and metastasis by enhancing antitumor immunity","volume":"16","author":"Vadevoo","year":"2017","journal-title":"Mol Cancer Ther."},{"key":"10.1016\/j.anai.2018.07.036_bib0036","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s10585-015-9747-9","article-title":"Targeting IL4\/IL4R for the treatment of epithelial cancer metastasis","volume":"32","author":"Bankaitis","year":"2015","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.anai.2018.07.036_bib0037","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ccr.2009.06.018","article-title":"CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages","volume":"16","author":"DeNardo","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.anai.2018.07.036_bib0038","first-page":"1594","article-title":"Expression of IL-4 and IL-13 predicts recurrence and survival in localized clear-cell renal cell carcinoma","volume":"8","author":"Chang","year":"2015","journal-title":"Int J Clin Exp Pathol."},{"key":"10.1016\/j.anai.2018.07.036_bib0039","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.leukres.2015.02.002","article-title":"Lymphoproliferative disease and cancer among patients with common variable immunodeficiency","volume":"39","author":"Gangemi","year":"2015","journal-title":"Leuk Res"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120618306227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120618306227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:20:32Z","timestamp":1761052832000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120618306227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S1081120618306227"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2018.07.036","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IgE deficiency and prior diagnosis of malignancy","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2018.07.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}